D. David Meek

Affiliations

  • Director at Fusion Pharmaceuticals Inc. (FUSN), 2023-10-16
  • Director at Uniqure N.v. (QURE), 2023-06-20
  • Chief Executive Officer at Mirati Therapeutics Inc. (MRTX), 2023-01-24
  • Director at Entasis Therapeutics Holdings Inc. (ETTX), 2022-07-11
  • Evp And President, Oncology at Baxalta Inc (BXLT), 2016-06-07
  • Chief Commercial Officer at Endocyte Inc (ECYT), 2014-02-10
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
QURE $18.85 2,290 Director 22,481 2023-06-16 Filing
QURE $19.71 389 Director 16,071 2023-02-27 Filing
MRTX $42.38 3,179 61,792 2023-01-17 Filing
MRTX $40.41 4,616 64,971 2022-12-21 Filing
QURE $16.70 602 Director 7,380 2022-02-28 Filing